To view this email as a web page, click here.

 
This may be why dermatitis flares in winter
A decrease in the levels of natural moisturizing factors and an increase in the density of corneocytes may explain why dermatitis and xerosis are worse in the winter.
ADVERTISEMENT
Less itch and more sleep with baricitinib
Rapid itch reduction was seen as early as one week in this phase 2 data studying Baricitinib for the treatment of Moderate to Severe Atopic Dermatitis (AD). Baricitinib is a once-daily oral Janus kinase (JAK) 1 and 2 inhibitor. The JAK’s will soon be coming to the world of Dermatology specifically in Psoriasis, Psoriatic Arthritis and Atopic Dermatitis.
ADVERTISEMENT
Adjusting melanoma dosing schedule may improve response rates
Changing the schedule of targeted therapies has been shown to improve the response rate in a mouse model of melanoma.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Is it time to update your laser devices?
What are the benefits of new laser technologies, and how do they impact your patients? In this podcast, we’ll examine the evolution of lasers and how new technologies are addressing patients’ needs. Listen to the podcast now.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.